Journal of Clinical Oncology (JCO) Podcast

The JCO Podcast hosted by Dr. Shannon Westin features discussions of new and noteworthy results publ

Episodes

Total: 418

The Addition of Another Camptothecin Fails to Improve Outcomes in Patients With Intermediate-Risk Rhabdomyosarcoma
2018/8/9

Read the related article "Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and C

Psychosocial Outcomes Following Contralateral Prophylactic Mastectomy: Insights and Opportunities
2018/7/25

Discussion of a recent study that evaluated prospectively psychosocial well being measures in breast

Risky Business: PD-1 Immune Checkpoint Blockade in Thymic Epithelial Neoplasms
2018/6/18

This podcast discusses the important risks and potential benefits of PD-1 immune checkpoint blockade

Don't Treat Me Like a Child: The Intensification of Conventional Chemotherapy in Adults With Acute Lymphoblastic Leukemia
2018/6/4

GRAALL-2005 study shows no overall benefit for cyclophosphamide intensification in older adults with

Multiple Myeloma Joins the Car T Race
2018/5/29

Highlighting the importance of BCMA-CAR T therapy for patients with relapsed refractory multiple mye

Cardiotoxicity After Breast Cancer Radiotherapy: Which Part of the Heart Matters Most?
2018/5/23

This podcast includes commentary upon a large case control series that examined the incidence of car

Should Prophylactic Cranial Irradiation Be Used in Patients with Stage III Non-Small Cell Lung Cancer?
2018/5/22

This is an evaluation of PCI in stage III Non-Small-Cell Lung Cancer.  While the incidence of sympto

The Medical Marijuana Conundrum: When Public Interest Outpaces Medical Knowledge
2018/5/11

The public perception of medical marijuana has outpaced medical knowledge. Oncologists encounter an

Racial Disparities in Medical Financial Hardship Among Cancer Survivors
2018/4/18

This commentary summarizes findings from a study of racial disparities in medical financial hardship

Late Infectious Death: Asplenic Adult Survivors of Child Cancer
2018/4/17

This  podcast discusses a CCSS study of very late infection-related mortality in asplenic adult surv

Extending the Reach of Targeted Therapy for Hormone Receptor-Positive Advanced Breast Cancer
2018/4/17

This podcast discusses a phase II trial evaluating the combination of everolimus and fulvestrant com

An International Phase II Trial of Single-Agent Nivolumab for Hodgkin Lymphoma Relapsed or Refractory After Autologous Stem Cell Transplant
2018/3/27

This podcast describes the extended follow-up of the large International phase II CheckMate 205 stud

Exploring a New Delivery Model for Germline Genetic Testing for Patients With Ovarian Cancer
2018/3/20

This podcast provides comment on the accompanying JCO article “ENGAGE: Evaluation of a streamlined o

Is Earlier Treatment Better For Patients? The Case of Docetaxel in Metastatic Castration-Sensitive Prostate Cancer
2018/3/9

This commentary examines whether patient-reported outcomes were substantially different in men given

The Decision to Image Breast Cancer Patients with Local-Regional Recurrence
2018/1/31

This podcast reflects upon a recent retrospective study of breast cancer patients with local regiona

The Importance of Reading Clinical Trial Protocols Simultaneously With Published Studies
2018/1/24

This podcast discusses whether the primary outcomes and study design for the reported trial were pro

Understanding the 'Value-Added' by Specialized Pediatric Palliative Care Teams in the Care of Children With Cancer at the End of Life
2018/1/22

This podcast reviews the aims, methodology, and results of a population-level study that investigate

Survival Following Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Early-Stage Hepatocellular Carcinoma
2018/1/12

This podcast reviews the current evidence for using radiofrequency ablation or stereotactic body rad

The True Costs of the 21-Gene Assay in a Cohort of 1,000 Patients
2017/12/1

This podcast addresses the clinical implications of the high cost of the 21-gene assay in women with